Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 3

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Gallium-68 × Clear all
NCT05490849 2023-02-22

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase EARLY_PHASE1 Unknown
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04554719 2023-02-14

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Unknown
500 enrolled
Tumor-Agnostic

Neoplasms

NCT05006326 2023-02-14

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Unknown
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡